Cancer-scanning device detects residual cancer cells post-surgery – Biotech’s future

submitted by: nsf

Despite a surgeon’s best efforts, residual cancer cells often remain after a tumor is removed. Now, a technology from NSF-funded small business NovaScan detects cancer cells in living tissue in real-time. The cancer-scanning device has already been used to find breast cancer cells. NovaScan’s William Gregory talked about how the wand works at the 2014 BIO International Convention.

Leveraging the immune system to fight cancer – Biotech’s future

submitted by: nsf

Inventors are using small-scale biology and engineering to find ways to use the body’s natural defenses to effectively treat cancer. NSF-funded small business GigaGen uses microfluidics, bioinformatics and genome sequencing to look for antibodies that may be good candidates for new therapies. GigaGen’s David Johnson explained how at the 2014 BIO International Convention.

Monitoring multiple biomarkers at once – Biotech’s future

submitted by: nsf

NSF-funded small business Applied Biosensors has created sensors that continuously monitor multiple biomarkers. The core technology has implications for biomedical research, water quality management and metabolic monitoring, among others. Prashant Tathireddy talked about the technology works at the 2014 BIO International Convention.

Clearing feeding tubes faster – Biotech’s future

submitted by: nsf

Feeding tubes often become clogged with medication and food, depriving patients of nutrition. NSF-funded small business Actuated Medical has invented an FDA-approved device that clears clogs quickly and cleanly. Roger Bagwell demonstrated how the device works at the 2014 BIO International Convention.

Translation Workflow Development using Mass Spectrometry

submitted by: Chrom Solutions
Mary Lopez, Ph.D. discusses translational workflows developed by the BRIMS center, designed to address all aspects of proteomics, from biomarker discovery to developing more routine applications using mass spectrometry. The workflows can be divided into two different types-- discovery and targeted. High-resolution mass spectrometry instruments are used during the discovery phase to analyze complex biological samples in an effort to uncover new biomarkers by looking at differential abundance....

San Jose Facility Now Registered as Medical Device Establishment

submitted by: Chrom Solutions

Thermo Fisher Scientific's San Jose, California facility registered with the U.S. Food and Drug Administration (FDA) as a medical device establishment. The site has established a quality system in accordance with the FDA Quality System Regulations to design and manufacture devices for analyzing samples from patients for in vitro diagnostic use.